Opus Genetics
IRD
14 hedge funds and large institutions have $898K invested in Opus Genetics in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.
72% more capital invested
Capital invested by funds: $523K → $898K (+$375K)
0.15% more ownership
Funds ownership: 1.82% → 1.97% (+0.15%)
18% less funds holding
Funds holding: 17 → 14 (-3)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$54.1K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
+$36.8K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$64 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$18K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6.24K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$2K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.62K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $594K | +$54.1K | +5,884 | +13% |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $156K | -$1.62K | -176 | -1% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $75K | – | – | – |
|
|
WS
4
Wedbush Securities
Los Angeles,
California
| $45K | +$36.8K | +4,000 | New |
|
5
BlackRock
New York
| $25K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $3K | -$6.24K | -679 | -71% |
|
|
APA
7
American Portfolios Advisors
Holbrook,
New York
| $23 | – | – | – |
|
|
CS
8
Credit Suisse
Zurich,
Switzerland
| – | -$18K | -2,550 | Closed |
|
|
9
Victory Capital Management
San Antonio,
Texas
| – | -$2K | -334 | Closed |
|
|
10
Bank of America
Charlotte,
North Carolina
| – | +$64 | +7 | New |
|
IRD Hedge Fund Activity: Q2 2020 in Review
14 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q2 2020, worth a combined $898K — up 72% from $523K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of IRD and 2 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $54.1K. The largest seller was Credit Suisse, exiting entirely with an estimated $18K sold.
- 14 institutional investors held Opus Genetics (IRD) as of Q2 2020, down from 17 in Q1 2020.
- Funds reported $898K of Opus Genetics stock for Q2 2020, up 72% quarter-over-quarter.
- 2 funds opened new Opus Genetics positions in Q2 2020 and 5 closed out, a net change of -3 holders.
- The largest Opus Genetics buyer in Q2 2020 was Renaissance Technologies, an estimated $54.1K added.
- The largest Opus Genetics seller in Q2 2020 was Credit Suisse, an estimated $18K sold.
Based on aggregated 13F filings for Q2 2020.